S. Abu-abed, G. Maclean, V. Fraulob, P. Chambon, M. Petkovich et al., Differential expression of the retinoic acid-metabolizing enzymes CYP26A1 and CYP26B1 during murine organogenesis, Mechanisms of Development, vol.110, issue.1-2, pp.173-177, 2002.
DOI : 10.1016/S0925-4773(01)00572-X

N. Ahmad and H. Mukhtar, Cytochrome P450: A Target for Drug Development for Skin Diseases, Journal of Investigative Dermatology, vol.123, issue.3, pp.417-425, 2004.
DOI : 10.1111/j.0022-202X.2004.23307.x

B. Al-lazikani, J. Jung, Z. Xiang, and B. Honig, Protein structure prediction, Current Opinion in Chemical Biology, vol.5, issue.1, pp.51-56, 2001.
DOI : 10.1016/S1367-5931(00)00164-2

M. Alirezai, S. George, I. Coutts, D. Roseeuw, J. Hachem et al., Daily treatment with adapalene gel 0.1% maintains initial improvement of acne vulgaris previously treated with oral lymecycline, European journal of dermatology : EJD, vol.17, pp.45-51, 2007.

L. Altucci, M. Leibowitz, K. Ogilvie, A. De-lera, and H. Gronemeyer, RAR and RXR modulation in cancer and metabolic disease, Nature Reviews Drug Discovery, vol.47, issue.10, pp.793-810, 2007.
DOI : 10.1038/nrd2397

URL : https://hal.archives-ouvertes.fr/hal-00192059

R. Arimoto, Computational Models for Predicting Interactions with Cytochrome p450 Enzyme, Current Topics in Medicinal Chemistry, vol.6, issue.15, pp.1609-1618, 2006.
DOI : 10.2174/156802606778108951

D. Asselineau, B. Bernard, C. Bailly, and M. Darmon, Retinoic acid improves epidermal morphogenesis, Developmental Biology, vol.133, issue.2, pp.322-335, 1989.
DOI : 10.1016/0012-1606(89)90037-7

M. Attar, D. Dong, K. Ling, and D. Tang-liu, Cytochrome P450 2C8 and flavin-containing monooxygenases are involved in the metabolism of tazarotenic acid in humans. Drug metabolism and disposition: the biological fate of chemicals 31, pp.476-481, 2003.

M. Attar, D. Yu, J. Ni, Z. Yu, K. Ling et al., Disposition and Biotransformation of the Acetylenic Retinoid Tazarotene in Humans, Journal of Pharmaceutical Sciences, vol.94, issue.10, pp.2246-2255, 2005.
DOI : 10.1002/jps.20427

J. Backman, C. Kyrklund, M. Neuvonen, and P. Neuvonen, Gemfibrozil greatly increases plasma concentrations of cerivastatin, Clinical Pharmacology & Therapeutics, vol.72, issue.6, pp.685-691, 2002.
DOI : 10.1067/mcp.2002.128469

H. Berman, J. Westbrook, Z. Feng, G. Gilliland, T. Bhat et al., The Protein Data Bank, Nucleic Acids Research, vol.28, issue.1, pp.235-242, 2000.
DOI : 10.1093/nar/28.1.235

T. Bjornsson, J. Callaghan, H. Einolf, V. Fischer, L. Gan et al., Pharmaceutical R, Manufacturers of America Drug Metabolism/Clinical Pharmacology Technical Working G, Evaluation FDACfD, and Research (2003a) The conduct of in vitro and in vivo drug-drug interaction studies: a Pharmaceutical Research and Manufacturers of America (PhRMA) perspective. Drug metabolism and disposition: the biological fate of chemicals 31, pp.815-832

T. Bjornsson, J. Callaghan, H. Einolf, V. Fischer, L. Gan et al., The Conduct of In Vitro and In Vivo Drug-Drug Interaction Studies: A PhRMA Perspective, Pharmaceutical R, and Manufacturers of America Drug Metabolism, pp.443-469, 2003.
DOI : 10.1177/0091270003252519

A. Blobaum, Mechanism-based inactivation and reversibility: is there a new trend in the inactivation of cytochrome p450 enzymes? Drug metabolism and disposition: the biological fate of chemicals, pp.1-7, 2006.

T. Blundell, B. Sibanda, R. Montalvao, S. Brewerton, V. Chelliah et al., Structural biology and bioinformatics in drug design: opportunities and challenges for target identification and lead discovery, Philosophical Transactions of the Royal Society B: Biological Sciences, vol.195, issue.4, pp.413-423, 2006.
DOI : 10.1016/0022-2836(87)90501-8

T. Blundell, B. Sibanda, M. Sternberg, and J. Thornton, Knowledge-based prediction of protein structures and the design of novel molecules, Nature, vol.326, issue.6111, pp.347-352, 1987.
DOI : 10.1038/326347a0

D. Boulton, U. Walle, and T. Walle, Extensive Binding of the Bioflavonoid Quercetin to Human Plasma Proteins, Journal of Pharmacy and Pharmacology, vol.16, issue.2, pp.243-249, 1998.
DOI : 10.1111/j.2042-7158.1998.tb06183.x

N. Brand, M. Petkovich, A. Krust, P. Chambon, H. De-the et al., Identification of a second human retinoic acid receptor, Nature, vol.16, issue.6167, pp.850-853, 1988.
DOI : 10.1038/327625a0

R. Brogden and K. Goa, Adapalene, Drugs, vol.53, issue.3, pp.511-519, 1997.
DOI : 10.2165/00003495-199753030-00010

G. Brown, B. Cash, D. Blihoghe, P. Johansson, A. Alnabulsi et al., The Expression and Prognostic Significance of Retinoic Acid Metabolising Enzymes in Colorectal Cancer, PLoS ONE, vol.222, issue.3, p.90776, 2014.
DOI : 10.1371/journal.pone.0090776.s007

W. Browne, A. North, D. Phillips, K. Brew, T. Vanaman et al., A possible three-dimensional structure of bovine ??-lactalbumin based on that of hen's egg-white lysozyme, Journal of Molecular Biology, vol.42, issue.1, pp.65-86, 1969.
DOI : 10.1016/0022-2836(69)90487-2

B. Buttrick, Characterization of selective and potent inhibitors of the human retinoic acid hydroxylases CYP26A1 and CYP26B1, Pharmaceutics, 2012.

C. Cavasotto and S. Phatak, Homology modeling in drug discovery: current trends and applications, Drug Discovery Today, vol.14, issue.13-14, pp.676-683, 2009.
DOI : 10.1016/j.drudis.2009.04.006

R. Chandraratna, Tazarotene-first of a new generation of receptor-selective retinoids, British Journal of Dermatology, vol.9, issue.Suppl., 1996.
DOI : 10.1111/j.1365-2133.1996.tb15662.x

B. Charpentier, J. Bernardon, J. Eustache, C. Millois, B. Martin et al., Synthesis, Structure-Affinity Relationships, and Biological Activities of Ligands Binding to Retinoic Acid Receptor Subtypes, Journal of Medicinal Chemistry, vol.38, issue.26, pp.4993-5006, 1995.
DOI : 10.1021/jm00026a006

H. Chen, A. Fantel, and M. Juchau, Catalysis of the 4-hydroxylation of retinoic acids by cyp3a7 in human fetal hepatic tissues. Drug metabolism and disposition: the biological fate of chemicals, pp.1051-1057, 2000.

H. Chen, W. Howald, and M. Juchau, Biosynthesis of all-trans-retinoic acid from alltrans-retinol: catalysis of all-trans-retinol oxidation by human P-450 cytochromes. Drug metabolism and disposition: the biological fate of chemicals, pp.315-322, 2000.

J. Cosme and E. Johnson, Engineering Microsomal Cytochrome P450 2C5 to Be a Soluble, Monomeric Enzyme: MUTATIONS THAT ALTER AGGREGATION, PHOSPHOLIPID DEPENDENCE OF CATALYSIS, AND MEMBRANE BINDING, Journal of Biological Chemistry, vol.275, issue.4, pp.2545-2553, 2000.
DOI : 10.1074/jbc.275.4.2545

T. Cunningham and G. Duester, Mechanisms of retinoic acid signalling and its roles in organ and limb development, Nature Reviews Molecular Cell Biology, vol.271, issue.2, pp.110-123, 2015.
DOI : 10.1038/nrm3932

C. Czaplewski, S. Rodziewicz-motowidlo, M. Dabal, A. Liwo, D. Ripoll et al., Molecular simulation study of cooperativity in hydrophobic association: clusters of four hydrophobic particles, Biophysical Chemistry, vol.105, issue.2-3, pp.339-359, 2003.
DOI : 10.1016/S0301-4622(03)00085-1

C. Czaplewski, S. Rodziewicz-motowidlo, A. Liwo, D. Ripoll, R. Wawak et al., Molecular simulation study of cooperativity in hydrophobic association, Protein Science, vol.106, issue.6, pp.1235-1245, 2000.
DOI : 10.1110/ps.9.6.1235

P. Daley-yates, R. Kunka, Y. Yin, S. Andrews, S. Callejas et al., Bioavailability of fluticasone propionate and mometasone furoate aqueous nasal sprays, European Journal of Clinical Pharmacology, vol.60, issue.4, pp.265-268, 2004.
DOI : 10.1007/s00228-004-0763-y

D. Coster, R. Wouters, W. Van-ginckel, R. End, D. Krekels et al., Experimental studies with liarozole (R 75 251): An antitumoral agent which inhibits retinoic acid breakdown, The Journal of Steroid Biochemistry and Molecular Biology, vol.43, issue.1-3, pp.197-201, 1992.
DOI : 10.1016/0960-0760(92)90208-Z

L. Deng, F. Wang, and H. Li, Effect of gemfibrozil on the pharmacokinetics of pioglitazone, European Journal of Clinical Pharmacology, vol.70, issue.11, pp.831-836, 2005.
DOI : 10.1007/s00228-005-0042-6

A. Di-masi, L. Leboffe, D. Marinis, E. Pagano, F. Cicconi et al., Retinoic acid receptors: From molecular mechanisms to cancer therapy, Molecular Aspects of Medicine, vol.41, pp.1-115, 2015.
DOI : 10.1016/j.mam.2014.12.003

X. Ding and L. Kaminsky, P450: Function in Xenobiotic Metabolism and Tissue-Selective Chemical Toxicity in the Respiratory and Gastrointestinal Tracts, Annual Review of Pharmacology and Toxicology, vol.43, issue.1, pp.149-173, 2003.
DOI : 10.1146/annurev.pharmtox.43.100901.140251

G. Duester, Retinoic Acid Synthesis and Signaling during Early Organogenesis, Cell, vol.134, issue.6, pp.921-931, 2008.
DOI : 10.1016/j.cell.2008.09.002

URL : http://doi.org/10.1016/j.cell.2008.09.002

M. Duvic, Tazarotene: a review of its pharmacological profile and potential for clinical use in psoriasis, Expert Opinion on Investigational Drugs, vol.72, issue.10, pp.1537-1551, 1997.
DOI : 10.1016/S0190-9622(94)70066-4

J. Eksterowicz, D. Rock, B. Rock, L. Wienkers, and R. Foti, Characterization of the active site properties of CYP4F12. Drug metabolism and disposition: the biological fate of chemicals, pp.1698-1707, 2014.

A. Filppula, J. Laitila, P. Neuvonen, and J. Backman, Reevaluation of the microsomal metabolism of montelukast: major contribution by CYP2C8 at clinically relevant concentrations. Drug metabolism and disposition: the biological fate of chemicals, pp.904-911, 2011.

P. Fiorella and J. Napoli, Expression of cellular retinoic acid binding protein (CRABP) in Escherichia coli. Characterization and evidence that holo-CRABP is a substrate in retinoic acid metabolism, The Journal of biological chemistry, vol.266, pp.16572-16579, 1991.

R. Foti and M. Fisher, Impact of incubation conditions on bufuralol human clearance predictions: enzyme lability and nonspecific binding. Drug metabolism and disposition: the biological fate of chemicals, pp.295-304, 2004.

R. Foti, M. Honaker, A. Nath, J. Pearson, B. Buttrick et al., Catalytic versus Inhibitory Promiscuity in Cytochrome P450s: Implications for Evolution of New Function, Biochemistry, vol.50, issue.13, pp.2387-2393, 2011.
DOI : 10.1021/bi1020716

R. Foti, N. Isoherranen, A. Zelter, L. Dickmann, B. Buttrick et al., Identification of Tazarotenic Acid as the First Xenobiotic Substrate of Human Retinoic Acid Hydroxylase CYP26A1 and CYP26B1, Journal of Pharmacology and Experimental Therapeutics, vol.357, issue.2, 2016.
DOI : 10.1124/jpet.116.232637

R. Foti, L. Wienkers, and J. Wahlstrom, Application of Cytochrome P450 Drug Interaction Screening in Drug Discovery, Combinatorial Chemistry & High Throughput Screening, vol.13, issue.2, pp.145-158, 2010.
DOI : 10.2174/138620710790596718

R. Friesner, J. Banks, R. Murphy, T. Halgren, J. Klicic et al., Glide:?? A New Approach for Rapid, Accurate Docking and Scoring. 1. Method and Assessment of Docking Accuracy, Journal of Medicinal Chemistry, vol.47, issue.7, pp.1739-1749, 2004.
DOI : 10.1021/jm0306430

R. Friesner, R. Murphy, M. Repasky, L. Frye, J. Greenwood et al., Extra Precision Glide:?? Docking and Scoring Incorporating a Model of Hydrophobic Enclosure for Protein???Ligand Complexes, Journal of Medicinal Chemistry, vol.49, issue.21, pp.6177-6196, 2006.
DOI : 10.1021/jm051256o

V. Giguere, Retinoic acid receptors and cellular retinoid binding proteins: complex interplay in retinoid signaling, Endocrine reviews, vol.15, pp.61-79, 1994.

V. Giguere, E. Ong, P. Segui, and R. Evans, Identification of a receptor for the morphogen retinoic acid, Nature, vol.330, issue.6149, pp.624-629, 1987.
DOI : 10.1038/330624a0

C. Gleiter and K. Morike, Clinical Pharmacokinetics of Candesartan, Clinical Pharmacokinetics, vol.12, issue.1, pp.7-17, 2002.
DOI : 10.2165/00003088-200241010-00002

M. Gomaa, J. Armstrong, B. Bobillon, G. Veal, A. Brancale et al., Novel azolyl-(phenylmethyl)]aryl/heteroarylamines: Potent CYP26 inhibitors and enhancers of all-trans retinoic acid activity in neuroblastoma cells, Bioorganic & Medicinal Chemistry, vol.16, issue.17, pp.8301-8313, 2008.
DOI : 10.1016/j.bmc.2007.06.048

M. Gomaa, C. Bridgens, A. Aboraia, G. Veal, C. Redfern et al., Small Molecule Inhibitors of Retinoic Acid 4-Hydroxylase (CYP26): Synthesis and Biological Evaluation of Imidazole Methyl 3-(4-(aryl-2-ylamino)phenyl)propanoates, Journal of Medicinal Chemistry, vol.54, issue.8, pp.2778-2791, 2011.
DOI : 10.1021/jm101583w

M. Gomaa, C. Bridgens, G. Veal, C. Redfern, A. Brancale et al., -Imidazol- and Triazol-1-yl)-2,2-dimethyl-3-[4-(naphthalen-2-ylamino)phenyl]propyl Derivatives as Small Molecule Inhibitors of Retinoic Acid 4-Hydroxylase (CYP26), Journal of Medicinal Chemistry, vol.54, issue.19, pp.6803-6811, 2011.
DOI : 10.1021/jm200695m

URL : https://hal.archives-ouvertes.fr/hal-00758332

M. Gomaa, S. Yee, C. Milbourne, M. Barbera, C. Simons et al., Homology Model of Human Retinoic Acid Metabolising Enzyme Cytochrome P450 26A1 (CYP26A1): Active Site Architecture and Ligand Binding, Journal of Enzyme Inhibition and Medicinal Chemistry, vol.98, issue.4, pp.361-369, 2006.
DOI : 10.1074/jbc.C400293200

G. Goodman, Goodman and Gilman's The Pharmacological Basis of Therapeutics, 2006.

J. Greer, Comparative modeling methods: Application to the family of the mammalian serine proteases, Proteins: Structure, Function, and Genetics, vol.50, issue.4, pp.317-334, 1990.
DOI : 10.1002/prot.340070404

L. Gudas and J. Wagner, Retinoids regulate stem cell differentiation, Journal of Cellular Physiology, vol.185, issue.5, pp.322-330, 2011.
DOI : 10.1002/jcp.22417

F. Guengerich, Human Cytochrome P450 Enzymes, Cytochrome P450: Structure, Mechanism, and Biochemistry Kluwer Academic, 2005.

T. Jaakkola, J. Backman, M. Neuvonen, and P. Neuvonen, Effects of gemfibrozil, itraconazole, and their combination on the pharmacokinetics of pioglitazone, Clinical Pharmacology & Therapeutics, vol.77, issue.5, pp.404-414, 2005.
DOI : 10.1016/j.clpt.2004.12.266

M. Jacobson, D. Pincus, C. Rapp, T. Day, B. Honig et al., A hierarchical approach to all-atom protein loop prediction, Proteins: Structure, Function, and Bioinformatics, vol.1, issue.2, pp.351-367, 2004.
DOI : 10.1002/prot.10613

B. John and A. Sali, Comparative protein structure modeling by iterative alignment, model building and model assessment, Nucleic Acids Research, vol.31, issue.14, pp.3982-3992, 2003.
DOI : 10.1093/nar/gkg460

W. Jorgensen, D. Maxwell, and J. Tirado-rives, Development and Testing of the OPLS All-Atom Force Field on Conformational Energetics and Properties of Organic Liquids, Journal of the American Chemical Society, vol.118, issue.45, pp.11225-11236, 1996.
DOI : 10.1021/ja9621760

W. Jorgensen and J. Tirado-rives, The OPLS [optimized potentials for liquid simulations] potential functions for proteins, energy minimizations for crystals of cyclic peptides and crambin, Journal of the American Chemical Society, vol.110, issue.6, pp.1657-1666, 1988.
DOI : 10.1021/ja00214a001

W. Jorgensen and J. Tirado-rives, Potential energy functions for atomic-level simulations of water and organic and biomolecular systems, Proceedings of the National Academy of Sciences, vol.102, issue.19, pp.6665-6670, 2005.
DOI : 10.1073/pnas.0408037102

G. Kaminski, E. Duffy, T. Matsui, and W. Jorgensen, Free Energies of Hydration and Pure Liquid Properties of Hydrocarbons from the OPLS All-Atom Model, The Journal of Physical Chemistry, vol.98, issue.49, pp.13077-13082, 1994.
DOI : 10.1021/j100100a043

M. Karlsson, Å. Strid, A. Sirsjö, and L. Eriksson, Homology Models and Molecular Modeling of Human Retinoic Acid Metabolizing Enzymes Cytochrome P450 26A1 (CYP26A1) and P450 26B1 (CYP26B1), Journal of Chemical Theory and Computation, vol.4, issue.6, pp.1021-1027, 2008.
DOI : 10.1021/ct800033x

T. Karonen, A. Filppula, J. Laitila, M. Niemi, P. Neuvonen et al., Gemfibrozil Markedly Increases the Plasma Concentrations of Montelukast: A Previously Unrecognized Role for CYP2C8 in the Metabolism of Montelukast, Clinical Pharmacology & Therapeutics, vol.29, issue.2, pp.223-230, 2010.
DOI : 10.1177/0091270007311569

T. Karonen, P. Neuvonen, and J. Backman, The CYP2C8 inhibitor gemfibrozil does not affect the pharmacokinetics of zafirlukast, European Journal of Clinical Pharmacology, vol.22, issue.6, pp.151-155, 2011.
DOI : 10.1007/s00228-010-0908-0

URL : https://hal.archives-ouvertes.fr/hal-00630277

T. Karonen, P. Neuvonen, and J. Backman, CYP2C8 but not CYP3A4 is important in the pharmacokinetics of montelukast, British Journal of Clinical Pharmacology, vol.19, issue.2, pp.257-267, 2012.
DOI : 10.1111/j.1365-2125.2011.04086.x

F. Khan, D. Wei, K. Gu, M. Hassan, and S. Tabrez, Current updates on computer aided protein modeling and designing, International Journal of Biological Macromolecules, vol.85, pp.48-62, 2016.
DOI : 10.1016/j.ijbiomac.2015.12.072

M. Kizaki, H. Ueno, Y. Yamazoe, M. Shimada, N. Takayama et al., Mechanisms of retinoid resistance in leukemic cells: possible role of cytochrome P450 and P-glycoprotein, Blood, vol.87, pp.725-733, 1996.

Y. Kosugi, H. Hirabayashi, T. Igari, Y. Fujioka, Y. Hara et al., Evaluation of cytochrome P450-mediated drug-drug interactions based on the strategies recommended by regulatory authorities. Xenobiotica; the fate of foreign compounds in biological systems, pp.127-138, 2012.

E. Krieger, G. Koraimann, and G. Vriend, Increasing the precision of comparative models with YASARA NOVA-a self-parameterizing force field, Proteins: Structure, Function, and Bioinformatics, vol.22, issue.3, pp.393-402, 2002.
DOI : 10.1002/prot.10104

E. Krieger, S. Nabuurs, and G. Vriend, Homology Modeling, 2003.
DOI : 10.1002/0471721204.ch25

S. Kuenzli and J. Saurat, Retinoids for the treatment of psoriasis: outlook for the future, Current opinion in investigational drugs, vol.2, pp.625-630, 2001.

R. Lotan, Effects of vitamin A and its analogs (retinoids) on normal and neoplastic cells, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, vol.605, issue.1, pp.33-91, 1980.
DOI : 10.1016/0304-419X(80)90021-9

O. Loudig, C. Babichuk, J. White, S. Abu-abed, C. Mueller et al., Cytochrome P450RAI(CYP26) Promoter: A Distinct Composite Retinoic Acid Response Element Underlies the Complex Regulation of Retinoic Acid Metabolism, Molecular Endocrinology, vol.14, issue.9, pp.1483-1497, 2000.
DOI : 10.1210/mend.14.9.0518

J. Lutz, V. Dixit, C. Yeung, L. Dickmann, A. Zelter et al., Expression and functional characterization of cytochrome P450 26A1, a retinoic acid hydroxylase, Biochemical Pharmacology, vol.77, issue.2, pp.258-268, 2009.
DOI : 10.1016/j.bcp.2008.10.012

A. Mackerell and . Jr, Empirical force fields for biological macromolecules: Overview and issues, Journal of Computational Chemistry, vol.50, issue.396, pp.1584-1604, 2004.
DOI : 10.1002/jcc.20082

M. Maden, Retinoid signalling in the development of the central nervous system, Nature Reviews Neuroscience, vol.128, issue.11, pp.843-853, 2002.
DOI : 10.1038/nrn963

C. Madhu, S. Duff, V. Baumgarten, P. Rix, D. Small et al., Metabolic Deesterification of Tazarotene in Human Blood and Rat and HumanLiver Microsomes, Journal of Pharmaceutical Sciences, vol.86, issue.8, pp.972-974, 1997.
DOI : 10.1021/js9700558

D. Mangelsdorf, U. Borgmeyer, R. Heyman, J. Zhou, E. Ong et al., Characterization of three RXR genes that mediate the action of 9-cis retinoic acid., Genes & Development, vol.6, issue.3, pp.329-344, 1992.
DOI : 10.1101/gad.6.3.329

J. Marill, C. Capron, N. Idres, and G. Chabot, Human cytochrome P450s involved in the metabolism of 9-cis- and 13-cis-retinoic acids, Biochemical Pharmacology, vol.63, issue.5, pp.933-943, 2002.
DOI : 10.1016/S0006-2952(01)00925-X

J. Marill, T. Cresteil, M. Lanotte, and G. Chabot, Identification of human cytochrome P450s involved in the formation of all-trans-retinoic acid principal metabolites, Mol Pharmacol, vol.58, pp.1341-1348, 2000.

J. Marill, N. Idres, C. Capron, E. Nguyen, and G. Chabot, Retinoic Acid Metabolism and Mechanism of Action: A Review, Current Drug Metabolism, vol.4, issue.1, pp.1-10, 2003.
DOI : 10.2174/1389200033336900

M. Mark, N. Ghyselinck, and P. Chambon, FUNCTION OF RETINOID NUCLEAR RECEPTORS: Lessons from Genetic and Pharmacological Dissections of the Retinoic Acid Signaling Pathway During Mouse Embryogenesis, Annual Review of Pharmacology and Toxicology, vol.46, issue.1, pp.451-480, 2006.
DOI : 10.1146/annurev.pharmtox.46.120604.141156

M. Marti-renom, A. Stuart, A. Fiser, R. Sanchez, F. Melo et al., Comparative Protein Structure Modeling of Genes and Genomes, Annual Review of Biophysics and Biomolecular Structure, vol.29, issue.1, pp.291-325, 2000.
DOI : 10.1146/annurev.biophys.29.1.291

P. Mccaffery and U. Drager, Regulation of retinoic acid signaling in the embryonic nervous system: a master differentiation factor, Cytokine & Growth Factor Reviews, vol.11, issue.3, pp.233-249, 2000.
DOI : 10.1016/S1359-6101(00)00002-2

D. Mcdougle, A. Palaria, E. Magnetta, D. Meling, and A. Das, Functional studies of N-terminally modified CYP2J2 epoxygenase in model lipid bilayers, Protein Science, vol.14, issue.7, pp.964-979, 2013.
DOI : 10.1002/pro.2280

L. Mcsorley and A. Daly, Identification of human cytochrome P450 isoforms that contribute to all-trans-retinoic acid 4-hydroxylation, Biochemical Pharmacology, vol.60, issue.4, pp.517-526, 2000.
DOI : 10.1016/S0006-2952(00)00356-7

E. Menegola, M. Broccia, D. Renzo, F. Giavini, and E. , Antifungal triazoles induce malformations in vitro, Reproductive Toxicology, vol.15, issue.4, pp.421-427, 2001.
DOI : 10.1016/S0890-6238(01)00143-5

A. Menter, Pharmacokinetics and safety of tazarotene, Journal of the American Academy of Dermatology, vol.43, issue.2, pp.31-35, 2000.
DOI : 10.1067/mjd.2000.108321

W. Miller and J. , The emerging role of retinoids and retinoic acid metabolism blocking agents in the treatment of cancer, Cancer, vol.37, issue.8, pp.1471-1482, 1998.
DOI : 10.1002/(SICI)1097-0142(19981015)83:8<1471::AID-CNCR1>3.0.CO;2-6

Y. Moon, L. Wang, R. Dicenzo, and M. Morris, Quercetin pharmacokinetics in humans, Biopharmaceutics & Drug Disposition, vol.666, issue.4, pp.205-217, 2008.
DOI : 10.1002/bdd.605

A. Morris, M. Macarthur, E. Hutchinson, and J. Thornton, Stereochemical quality of protein structure coordinates, Proteins: Structure, Function, and Genetics, vol.12, issue.4, pp.345-364, 1992.
DOI : 10.1002/prot.340120407

J. Muindi, S. Frankel, W. Miller, J. Jakubowski, A. Scheinberg et al., Continuous treatment with all-trans retinoic acid causes a progressive reduction in plasma drug concentrations: implications for relapse and retinoid "resistance" in patients with acute promyelocytic leukemia, Blood, vol.79, pp.299-303, 1992.

A. Murzin, Progress in protein structure prediction, Nature Structural Biology, vol.8, issue.2, pp.110-112, 2001.
DOI : 10.1038/84088

L. Nadin and M. Murray, Participation of CYP2C8 in retinoic acid 4-hydroxylation in human hepatic microsomes, Biochemical Pharmacology, vol.58, issue.7, pp.1201-1208, 1999.
DOI : 10.1016/S0006-2952(99)00192-6

A. Nath, M. Zientek, B. Burke, Y. Jiang, and W. Atkins, Quantifying and predicting the promiscuity and isoform specificity of small-molecule cytochrome P450 inhibitors. Drug metabolism and disposition: the biological fate of chemicals, pp.2195-2203, 2010.

A. Nayeem, D. Sitkoff, S. Krystek, and J. , A comparative study of available software for high-accuracy homology modeling: From sequence alignments to structural models, Protein Science, vol.15, issue.4, pp.808-824, 2006.
DOI : 10.1110/ps.051892906

C. Nelson, B. Buttrick, and N. Isoherranen, Therapeutic Potential of the Inhibition of the Retinoic Acid Hydroxylases CYP26A1 and CYP26B1 by Xenobiotics, Current Topics in Medicinal Chemistry, vol.13, issue.12, pp.1402-1428, 2013.
DOI : 10.2174/1568026611313120004

C. Nelson, J. Lutz, and N. Isoherranen, Cellular retinoic acid binding proteins (CRABPs) channel retinoic acid to CYP26A1, The FASEB Journal, vol.27, pp.892-896, 2013.

D. Nelson, Cytochrome P450 Nomenclature, Methods in molecular biology, vol.320, pp.1-10, 2004.
DOI : 10.1385/0-89603-519-0:15

K. Niederreither and P. Dolle, Retinoic acid in development: towards an integrated view, Nature Reviews Genetics, vol.126, issue.7, pp.541-553, 2008.
DOI : 10.1038/nrg2340

URL : https://hal.archives-ouvertes.fr/inserm-00311222

M. Niemi, J. Backman, M. Granfors, J. Laitila, M. Neuvonen et al., Gemfibrozil considerably increases the plasma concentrations of rosiglitazone, Diabetologia, vol.46, issue.10, pp.1319-1323, 2003.
DOI : 10.1007/s00125-003-1181-x

M. Niemi, A. Tornio, M. Pasanen, H. Fredrikson, P. Neuvonen et al., Itraconazole, gemfibrozil and their combination markedly raise the plasma concentrations of loperamide, European Journal of Clinical Pharmacology, vol.35, issue.6, pp.463-472, 2006.
DOI : 10.1007/s00228-006-0133-z

V. Njar, Cytochrome P450 Retinoic Acid 4-Hydroxylase Inhibitors: Potential Agents for Cancer Therapy, Mini reviews in medicinal chemistry, pp.261-269, 2002.
DOI : 10.2174/1389557023406223

V. Njar, L. Gediya, P. Purushottamachar, P. Chopra, T. Vasaitis et al., Retinoic acid metabolism blocking agents (RAMBAs) for treatment of cancer and dermatological diseases, Bioorganic & Medicinal Chemistry, vol.14, issue.13, pp.4323-4340, 2006.
DOI : 10.1016/j.bmc.2006.02.041

N. Noy, Retinoid-binding proteins: mediators of retinoid action, The Biochemical journal 348 Pt, vol.3, pp.481-495, 2000.

R. Obach, J. Baxter, T. Liston, B. Silber, B. Jones et al., The prediction of human pharmacokinetic parameters from preclinical and in vitro metabolism data, The Journal of pharmacology and experimental therapeutics, vol.283, pp.46-58, 1997.

P. Ortiz-de-montellano, D. Voss, and J. , Oxidizing species in the mechanism of cytochrome P450, Natural Product Reports, vol.19, issue.4, pp.477-493, 2002.
DOI : 10.1039/b101297p

M. Osanai and G. Lee, Enhanced expression of retinoic acid-metabolizing enzyme CYP26A1 in sunlight-damaged human skin, Medical Molecular Morphology, vol.392, issue.pt1, pp.200-206, 2011.
DOI : 10.1007/s00795-010-0528-x

B. Pawson, C. Ehmann, L. Itri, and M. Sherman, Retinoids at the threshold: their biological significance and therapeutic potential, Journal of Medicinal Chemistry, vol.25, issue.11, pp.1269-1277, 1982.
DOI : 10.1021/jm00353a001

E. Perola, W. Walters, and P. Charifson, A detailed comparison of current docking and scoring methods on systems of pharmaceutical relevance, Proteins: Structure, Function, and Bioinformatics, vol.17, issue.Suppl 1, pp.235-249, 2004.
DOI : 10.1002/prot.20088

M. Petkovich, N. Brand, A. Krust, and P. Chambon, A human retinoic acid receptor which belongs to the family of nuclear receptors, Nature, vol.330, issue.6147, pp.444-450, 1987.
DOI : 10.1038/330444a0

G. Pierard, C. Pierard-franchimont, P. Paquet, and P. Quatresooz, Spotlight on adapalene, Expert Opinion on Drug Metabolism & Toxicology, vol.5, issue.12, pp.1565-1575, 2009.
DOI : 10.1016/j.jaad.2005.12.043

T. Poulous and E. Johnson, Structures of Cytochrome P450 Enzymes, Cytochrome P450: Structure, Mechanism and Biochemistry Kluwer Academic, 2005.

P. Purushottamachar, J. Patel, L. Gediya, O. Clement, and V. Njar, First chemical feature-based pharmacophore modeling of potent retinoidal retinoic acid metabolism blocking agents (RAMBAs): Identification of novel RAMBA scaffolds, European Journal of Medicinal Chemistry, vol.47, pp.412-423, 2012.
DOI : 10.1016/j.ejmech.2011.11.010

J. Ransom, P. Morgan, P. Mccaffery, and P. Stoney, The rhythm of retinoids in the brain, Journal of Neurochemistry, vol.13, issue.3, pp.366-376, 2014.
DOI : 10.1111/jnc.12620

M. Raverdeau, A. Gely-pernot, B. Feret, C. Dennefeld, G. Benoit et al., Retinoic acid induces Sertoli cell paracrine signals for spermatogonia differentiation but cell autonomously drives spermatocyte meiosis, Proceedings of the National Academy of Sciences, vol.109, issue.41, pp.16582-16587, 2012.
DOI : 10.1073/pnas.1214936109

URL : https://hal.archives-ouvertes.fr/hal-00749600

M. Raverdeau and K. Mills, Modulation of T Cell and Innate Immune Responses by Retinoic Acid, The Journal of Immunology, vol.192, issue.7, pp.2953-2958, 2014.
DOI : 10.4049/jimmunol.1303245

W. Ray, G. Bain, M. Yao, and D. Gottlieb, CYP26, a Novel Mammalian Cytochrome P450, Is Induced by Retinoic Acid and Defines a New Family, Journal of Biological Chemistry, vol.272, issue.30, pp.18702-18708, 1997.
DOI : 10.1074/jbc.272.30.18702

J. Ren, X. Xiong, Y. Sha, M. Yan, B. Lin et al., Structure prediction and R115866 binding study of human CYP26A1: homology modelling, fold recognition, molecular docking and MD simulations, Molecular Simulation, vol.293, issue.3, pp.337-346, 2008.
DOI : 10.1093/jac/45.3.371

T. Roos, F. Jugert, H. Merk, and D. Bickers, Retinoid metabolism in the skin, Pharmacological reviews, vol.50, pp.315-333, 1998.

A. Ross and R. Zolfaghari, Cytochrome P450s in the Regulation of Cellular Retinoic Acid Metabolism, Annual Review of Nutrition, vol.31, issue.1, pp.65-87, 2011.
DOI : 10.1146/annurev-nutr-072610-145127

S. Ross, P. Mccaffery, U. Drager, D. Luca, and L. , Retinoids in embryonal development, Physiological reviews, vol.80, pp.1021-1054, 2000.

S. Rowbotham, A. Boddy, C. Redfern, G. Veal, and A. Daly, Relevance of nonsynonymous CYP2C8 polymorphisms to 13-cis retinoic acid and paclitaxel hydroxylation. Drug metabolism and disposition: the biological fate of chemicals, pp.1261-1266, 2010.

P. Saenz-mendez, A. Elmabsout, H. Savenstrand, M. Awadalla, A. Strid et al., Homology Models of Human All-Trans Retinoic Acid Metabolizing Enzymes CYP26B1 and CYP26B1 Spliced Variant, Journal of Chemical Information and Modeling, vol.52, issue.10, pp.2631-2637, 2012.
DOI : 10.1021/ci300264u

R. Sanchez and A. Sali, Advances in comparative protein-structure modelling, Current Opinion in Structural Biology, vol.7, issue.2, pp.206-214, 1997.
DOI : 10.1016/S0959-440X(97)80027-9

R. Sanchez and A. Sali, Evaluation of comparative protein structure modeling by MODELLER-3, Proteins, vol.1, pp.50-58, 1997.

S. Saperstein, R. Edgren, G. Lee, D. Jung, A. Fratis et al., Bioequivalence of two oral contraceptive drugs containing norethindrone and ethinyl estradiol, Contraception, vol.40, issue.5, pp.581-590, 1989.
DOI : 10.1016/0010-7824(89)90130-3

P. Sawyer, R. Brogden, R. Pinder, T. Speight, and A. , Clotrimazole, Drugs, vol.9, issue.6, pp.424-447, 1975.
DOI : 10.2165/00003495-197509060-00003

A. Saxena, R. Sangwan, and S. Mishra, Fundamentals of homology modeling steps and comparison among important bioinformatics tools: An overview, Science International, vol.1, p.237, 2013.

J. Schenkman and I. Jansson, Spectral Analyses of Cytochromes P450, Cytochrome P450 Protocols, 2006.

G. Schoch, J. Yano, S. Sansen, P. Dansette, C. Stout et al., Determinants of Cytochrome P450 2C8 Substrate Binding: STRUCTURES OF COMPLEXES WITH MONTELUKAST, TROGLITAZONE, FELODIPINE, AND 9-CIS-RETINOIC ACID, Journal of Biological Chemistry, vol.283, issue.25, pp.17227-17237, 2008.
DOI : 10.1074/jbc.M802180200

G. Schoch, J. Yano, M. Wester, K. Griffin, C. Stout et al., Structure of Human Microsomal Cytochrome P450 2C8: EVIDENCE FOR A PERIPHERAL FATTY ACID BINDING SITE, Journal of Biological Chemistry, vol.279, issue.10, pp.9497-9503, 2004.
DOI : 10.1074/jbc.M312516200

E. Schwartz, S. Hallam, R. Gallagher, and P. Wiernik, Inhibition of all-trans-retinoic acid metabolism by fluconazole in vitro and in patients with acute promyelocytic leukemia, Biochemical Pharmacology, vol.50, issue.7, pp.923-928, 1995.
DOI : 10.1016/0006-2952(95)00213-J

W. Sherman, H. Beard, and R. Farid, Use of an Induced Fit Receptor Structure in Virtual Screening, Chemical Biology <html_ent glyph="@amp;" ascii="&"/> Drug Design, vol.49, issue.1, pp.83-84, 2006.
DOI : 10.1111/j.1747-0285.2005.00327.x

W. Sherman, T. Day, M. Jacobson, R. Friesner, and R. Farid, Novel Procedure for Modeling Ligand/Receptor Induced Fit Effects, Journal of Medicinal Chemistry, vol.49, issue.2, pp.534-553, 2006.
DOI : 10.1021/jm050540c

J. Shimshoni, A. Roberts, M. Scian, A. Topletz, S. Blankert et al., Stereoselective Formation and Metabolism of 4-Hydroxy-Retinoic Acid Enantiomers by Cytochrome P450 Enzymes, Journal of Biological Chemistry, vol.287, issue.50, pp.42223-42232, 2012.
DOI : 10.1074/jbc.M112.404475

M. Sippl, Knowledge-based potentials for proteins, Current Opinion in Structural Biology, vol.5, issue.2, pp.229-235, 1995.
DOI : 10.1016/0959-440X(95)80081-6

K. Sloczynska, A. Gunia-krzyzak, D. Zelaszczyk, A. Waszkielewicz, and H. Marona, Skin metabolism established with the use of MetaSite for selected retinoids employed in topical and systemic treatment of various skin disorders and found in cosmeceuticals, 2015.

E. Sonneveld, C. Van-den-brink, B. Van-der-leede, R. Schulkes, M. Petkovich et al., Human retinoic acid (RA) 4-hydroxylase (CYP26) is highly specific for all-trans-RA and can be induced through RA receptors in human breast and colon carcinoma cells, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research, vol.9, pp.629-637, 1998.

M. Sporn and A. Roberts, Role of retinoids in differentiation and carcinogenesis, Journal of the National Cancer Institute, vol.73, pp.1381-1387, 1984.

B. Sun, S. Song, C. Hao, W. Huang, C. Liu et al., Molecular recognition of CYP26A1 binding pockets and structure???activity relationship studies for design of potent and selective retinoic acid metabolism blocking agents, Journal of Molecular Graphics and Modelling, vol.56, pp.10-19, 2015.
DOI : 10.1016/j.jmgm.2014.11.014

M. Taimi, C. Helvig, J. Wisniewski, H. Ramshaw, J. White et al., A Novel Human Cytochrome P450, CYP26C1, Involved in Metabolism of 9-cis and All-trans Isomers of Retinoic Acid, Journal of Biological Chemistry, vol.279, issue.1, pp.77-85, 2004.
DOI : 10.1074/jbc.M308337200

R. Talpur, K. Cox, and M. Duvic, Efficacy and safety of topical tazarotene: a review, Expert Opinion on Drug Metabolism & Toxicology, vol.68, issue.2, pp.195-210, 2009.
DOI : 10.1111/j.1529-8019.2006.00082.x

J. Vermilion, D. Ballou, V. Massey, and M. Coon, Separate roles for FMN and FAD in catalysis by liver microsomal NADPH-cytochrome P-450 reductase, The Journal of biological chemistry, vol.256, pp.266-277, 1981.

J. Vermilion and M. Coon, Identification of the high and low potential flavins of liver microsomal NADPH-cytochrome P-450 reductase, The Journal of biological chemistry, vol.253, pp.8812-8819, 1978.

A. Volkamer, D. Kuhn, T. Grombacher, F. Rippmann, and M. Rarey, Combining Global and Local Measures for Structure-Based Druggability Predictions, Journal of Chemical Information and Modeling, vol.52, issue.2, pp.360-372, 2012.
DOI : 10.1021/ci200454v

C. Von-wachenfeldt, T. Richardson, J. Cosme, and J. Ef, Microsomal P450 2C3 Is Expressed as a Soluble Dimer inEscherichia coliFollowing Modifications of Its N-terminus, Archives of Biochemistry and Biophysics, vol.339, issue.1, pp.107-114, 1997.
DOI : 10.1006/abbi.1996.9859

R. Walsky, E. Gaman, and R. Obach, Examination of 209 Drugs for Inhibition of Cytochrome P450 2C8, The Journal of Clinical Pharmacology, vol.311, issue.1, pp.68-78, 2005.
DOI : 10.1177/0091270004270642

I. Walter-sack, J. De-vries, A. Ittensohn, M. Kohlmeier, and W. E. , Benzbromarone disposition and uricosuric action; evidence for hydroxilation instead of debromination to benzarone, Klinische Wochenschrift, vol.95, issue.Suppl X, pp.160-166, 1988.
DOI : 10.1007/BF01727785

F. Wang, H. Kwak, N. Elbuluk, A. Kaczmarek, T. Hamilton et al., Retinoic acid 4-hydroxylase inducibility and clinical response to isotretinoin in patients with acne, Journal of the American Academy of Dermatology, vol.61, issue.2, pp.252-258, 2009.
DOI : 10.1016/j.jaad.2009.03.013

Y. Wang, R. Zolfaghari, and R. Ac, Cloning of rat cytochrome P450RAI (CYP26) cDNA and regulation of its gene expression by all-trans-retinoic acid in vivo, Archives of Biochemistry and Biophysics, vol.401, issue.2, pp.235-243, 2002.
DOI : 10.1016/S0003-9861(02)00043-7

J. Waugh, S. Noble, and L. Scott, Adapalene, Drugs, vol.47, issue.4, pp.1465-1478, 2004.
DOI : 10.2165/00003495-200464130-00005

S. Weiner, P. Kollman, D. Case, U. Singh, C. Ghio et al., A new force field for molecular mechanical simulation of nucleic acids and proteins, Journal of the American Chemical Society, vol.106, issue.3, pp.765-784, 1984.
DOI : 10.1021/ja00315a051

J. Westbrook, Z. Feng, S. Jain, T. Bhat, N. Thanki et al., The Protein Data Bank: unifying the archive, Nucleic Acids Research, vol.30, issue.1, pp.245-248, 2002.
DOI : 10.1093/nar/30.1.245

J. White, Y. Guo, K. Baetz, B. Beckett-jones, J. Bonasoro et al., Identification of the Retinoic Acid-inducible All-trans-retinoic Acid 4-Hydroxylase, Journal of Biological Chemistry, vol.271, issue.47, pp.29922-29927, 1996.
DOI : 10.1074/jbc.271.47.29922

J. White, H. Ramshaw, M. Taimi, W. Stangle, A. Zhang et al., Identification of the human cytochrome P450, P450RAI-2, which is predominantly expressed in the adult cerebellum and is responsible for all-trans-retinoic acid metabolism, Proceedings of the National Academy of Sciences, vol.97, issue.12, pp.6403-6408, 2000.
DOI : 10.1073/pnas.120161397

J. Williams and J. Napoli, Inhibition of retinoic acid metabolism by imidazole antimycotics in F9 embryonal carcinoma cells, Biochemical Pharmacology, vol.36, issue.8, pp.1386-1388, 1987.
DOI : 10.1016/0006-2952(87)90102-X

P. Williams, J. Cosme, V. Sridhar, E. Johnson, and M. De, Mammalian Microsomal Cytochrome P450 Monooxygenase, Molecular Cell, vol.5, issue.1, pp.121-131, 2000.
DOI : 10.1016/S1097-2765(00)80408-6

J. Xi and Y. Z. , Expression of RALDHs (ALDH1As) and CYP26s in human tissues and during the neural differentiation of P19 embryonal carcinoma stem cell, Gene Expression Patterns, vol.8, issue.6, pp.438-442, 2008.
DOI : 10.1016/j.gep.2008.04.003

Z. Xiang, Advances in Homology Protein Structure Modeling, Current Protein & Peptide Science, vol.7, issue.3, pp.217-227, 2006.
DOI : 10.2174/138920306777452312

L. Xu, R. Sanchez, A. Sali, and N. Heintz, Ligand specificity of brain lipid-binding protein, The Journal of biological chemistry, vol.271, pp.24711-24719, 1996.

H. Yamazaki and T. Shimada, Effects of arachidonic acid, prostaglandins, retinol, retinoic acid and cholecalciferol on xenobiotic oxidations catalysed by human cytochrome P450 enzymes. Xenobiotica; the fate of foreign compounds in biological systems, pp.231-241, 1999.

P. Modeling and 3. , Homology Modeling and Docking Studies on CYP11B1 Inhibitors, Molecules, vol.20, pp.1014-1030

Z. Yu, J. Sefton, D. Lew-kaya, P. Walker, D. Yu et al., Pharmacokinetics of Tazarotene Cream 0.1% After a Single Dose and After Repeat Topical Applications at Clinical or Exaggerated Application Rates in Patients with Acne Vulgaris or Photodamaged Skin, Clinical Pharmacokinetics, vol.37, issue.10, pp.921-929, 2003.
DOI : 10.2165/00003088-200342100-00004

U. Zanger and M. Schwab, Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation, Pharmacology & Therapeutics, vol.138, issue.1, pp.103-141, 2013.
DOI : 10.1016/j.pharmthera.2012.12.007

Q. Zhang, D. Dunbar, and L. Kaminsky, Human cytochrome P-450 metabolism of retinals to retinoic acids. Drug metabolism and disposition: the biological fate of chemicals, pp.292-297, 2000.

Y. Zhang, Progress and challenges in protein structure prediction, Current Opinion in Structural Biology, vol.18, issue.3, pp.342-348, 2008.
DOI : 10.1016/j.sbi.2008.02.004